2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$39.82+$0.57 (+1.45%)
Price as of Oct 22, 2026 7:30 PM EDT- $828.4MMarket Cap
- -1.12%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$39.82+$0.57 (+1.45%)
PAHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.25 | ||
Change | +$0.45 (+1.16%) | ||
Open | $38.74 | ||
High | $39.36 | ||
Low | $38.11 | ||
Previous Close | $38.80 | ||
Volume | 169,199 | ||
30-Day Average Volume | 219,404 | ||
1-Week Change | 3.48% | ||
1-Month Change | 13.18% | ||
1-Year Change | -1.12% | ||
3-Year Change | 256.19% | ||
5-Year Change | 98.39% | ||
Fundamentals | |||
Shares Outstanding | 21.1M | ||
Total Assets | $1.5B | ||
Market Cap | $828.4M | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $396.7M | ||
Net Income | $21.7M | ||
Free Cash Flow | $5.2M | ||
EBIT | $42.5M | ||
EBITDA | $55.9M | ||
Net Working Capital | $619.0M | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 74 | ||
PEG | -7 | ||
Price/Free Cash Flow | 159 | ||
Price/Operating Cash Flow | 34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.22% | ||
Trailing Annual Dividend Yield | 1.22% | ||
Ex-Dividend Date | 09/02/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield